513 related articles for article (PubMed ID: 9718306)
1. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
[TBL] [Abstract][Full Text] [Related]
2. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.
Pullen SS; Labadia ME; Ingraham RH; McWhirter SM; Everdeen DS; Alber T; Crute JJ; Kehry MR
Biochemistry; 1999 Aug; 38(31):10168-77. PubMed ID: 10433725
[TBL] [Abstract][Full Text] [Related]
3. Cutting edge: contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation.
Hostager BS; Bishop GA
J Immunol; 1999 Jun; 162(11):6307-11. PubMed ID: 10352240
[TBL] [Abstract][Full Text] [Related]
4. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor receptor-associated factors (TRAFs).
Bradley JR; Pober JS
Oncogene; 2001 Oct; 20(44):6482-91. PubMed ID: 11607847
[TBL] [Abstract][Full Text] [Related]
7. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
[TBL] [Abstract][Full Text] [Related]
8. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells.
Izban KF; Ergin M; Martinez RL; Alkan S
Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929
[TBL] [Abstract][Full Text] [Related]
9. Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily.
Boucher LM; Marengère LE; Lu Y; Thukral S; Mak TW
Biochem Biophys Res Commun; 1997 Apr; 233(3):592-600. PubMed ID: 9168896
[TBL] [Abstract][Full Text] [Related]
10. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs.
Pullen SS; Dang TT; Crute JJ; Kehry MR
J Biol Chem; 1999 May; 274(20):14246-54. PubMed ID: 10318845
[TBL] [Abstract][Full Text] [Related]
11. Distinct molecular mechanism for initiating TRAF6 signalling.
Ye H; Arron JR; Lamothe B; Cirilli M; Kobayashi T; Shevde NK; Segal D; Dzivenu OK; Vologodskaia M; Yim M; Du K; Singh S; Pike JW; Darnay BG; Choi Y; Wu H
Nature; 2002 Jul; 418(6896):443-7. PubMed ID: 12140561
[TBL] [Abstract][Full Text] [Related]
12. NF-kappaB activation in CD27 signaling: involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27.
Yamamoto H; Kishimoto T; Minamoto S
J Immunol; 1998 Nov; 161(9):4753-9. PubMed ID: 9794406
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for self-association and receptor recognition of human TRAF2.
Park YC; Burkitt V; Villa AR; Tong L; Wu H
Nature; 1999 Apr; 398(6727):533-8. PubMed ID: 10206649
[TBL] [Abstract][Full Text] [Related]
14. TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells.
Grammer AC; Swantek JL; McFarland RD; Miura Y; Geppert T; Lipsky PE
J Immunol; 1998 Aug; 161(3):1183-93. PubMed ID: 9686578
[TBL] [Abstract][Full Text] [Related]
15. Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway.
Sasai M; Tatematsu M; Oshiumi H; Funami K; Matsumoto M; Hatakeyama S; Seya T
Mol Immunol; 2010 Mar; 47(6):1283-91. PubMed ID: 20047764
[TBL] [Abstract][Full Text] [Related]
16. Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B.
Jang IK; Lee ZH; Kim YJ; Kim SH; Kwon BS
Biochem Biophys Res Commun; 1998 Jan; 242(3):613-20. PubMed ID: 9464265
[TBL] [Abstract][Full Text] [Related]
17. Distinct contributions of different CD40 TRAF binding sites to CD154-induced dendritic cell maturation and IL-12 secretion.
Mackey MF; Wang Z; Eichelberg K; Germain RN
Eur J Immunol; 2003 Mar; 33(3):779-89. PubMed ID: 12616498
[TBL] [Abstract][Full Text] [Related]
18. Cooperation of both TNF receptors in inducing apoptosis: involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75.
Declercq W; Denecker G; Fiers W; Vandenabeele P
J Immunol; 1998 Jul; 161(1):390-9. PubMed ID: 9647248
[TBL] [Abstract][Full Text] [Related]
19. CD40-mediated signals inhibit the binding of TNF receptor-associated factor 2 to the CD40 cytoplasmic domain.
Chaudhuri A; Orme S; Eilam S; Cherayil BJ
J Immunol; 1997 Nov; 159(9):4244-51. PubMed ID: 9379019
[TBL] [Abstract][Full Text] [Related]
20. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.
Hsing Y; Hostager BS; Bishop GA
J Immunol; 1997 Nov; 159(10):4898-906. PubMed ID: 9366415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
